Boardroom Alpha
Meeting calendar
GTES · Annual meeting · Thursday, June 4, 2026

Gates Industrial Corp PLC

8 nominees · 8 ballot items.

Eight proposals: (1) election of eight directors; (2) advisory say-on-pay approval of named executive officer compensation; (3) advisory approval of the Directors’ Remuneration Report under the U.K. Companies Act; (4) ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal 2026; (5) re‑appointment of Deloitte LLP as the Company’s U.K. statutory auditor; (6) authorization for the Audit Committee to determine Deloitte LLP’s remuneration; (7) authorization for the Board to allot equity securities (up to ~20% of issued share capital); and (8) subject to Proposal 7, authorization for the Board to allot equity securities for cash without pre-emptive rights (up to ~20%).

Market cap
$6.7B
1Y TSR
+11.0%
Board grade
B-
Record date
Apr 7, 2026
Filing
DEF 14A
Meeting concluded · Jun 4, 2026

Follow how the vote landed and what changed on Gates Industrial Corp PLC’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot8

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Re-election of eight incumbent directors each to serve a one-year term until the 2027 AGM.

  2. 2

    Advisory Vote To Approve NEO Compensation

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the Company’s named executive officers as described in the proxy statement (say-on-pay).

    More detail

    This non-binding advisory (say-on-pay) proposal asks shareholders to approve the compensation paid to the Company’s named executive officers as disclosed in the proxy statement. Management frames executive pay as strongly weighted toward at‑risk, performance-based compensation—mixing annual cash incentives tied to Adjusted EBITDA, Free Cash Flow and Revenue with long‑term equity awards that are 50% performance‑based (PRSUs) and 50% time‑vested RSUs, with PRSUs measured by Adjusted ROIC and Relative TSR. The Board says the structure aligns executives’ incentives with long‑term shareholder value, uses market peer benchmarking and an independent consultant, and includes governance features such as clawbacks, equity ownership guidelines and double‑trigger change‑in‑control protections. Although advisory and non‑binding, the Board commits to consider shareholder feedback from the vote when reviewing compensation programs. For sophisticated evaluation, note the Company’s strong pay‑for‑performance posture (high CEO variable pay), detailed performance metrics, and prior-year high say‑on‑pay support (over 98% in 2025), which suggests limited shareholder opposition historically. Potential concerns for investors include high upside caps (200% maximum payouts), complexity of adjustments (discretion to exclude unusual items and FX impacts), and substantial CEO realized compensation in years with strong equity vesting. Overall, a vote FOR reflects the Board’s view that the program aligns management with multi‑year operational and market performance while a vote AGAINST would signal investor dissatisfaction with governance, pay quantum, or specific performance metric settings. The Board recommends FOR while acknowledging the advisory nature of the vote and its intent to consider results in future compensation decisions.

  3. 3

    Advisory Vote On Directors’ Remuneration Report

    ManagementBoard: FOR

    Non-binding advisory vote to approve the Directors’ Remuneration Report (U.K. Companies Act requirement) contained in Appendix A.

    More detail

    This advisory resolution requests shareholder approval of the Directors’ Remuneration Report required under the U.K. Companies Act, which summarizes remuneration policy and implementation for executive and non‑executive directors. Management presents the report as aligning with the Company’s pay‑for‑performance philosophy, detailing executive base salary, annual bonus design, and long‑term incentives (RSUs and PRSUs tied to Adjusted ROIC and Relative TSR), along with director fees and benefits. The report documents governance safeguards including independent consultant review, committee oversight, share ownership guidelines, clawback policy, and double‑trigger change‑in‑control protections. Because it is advisory, passage does not legally bind the Board, but the Board indicates it will consider vote outcomes when shaping future remuneration policy. Analysts should weigh the content against historical say‑on‑pay outcomes (strong prior support), the specifics of policy changes (e.g., metrics weightings), and the degree to which compensation outcomes reflect realized shareholder value. A FOR vote signals shareholder support for the remuneration implementation and policies described; a vote AGAINST would indicate concerns about levels, alignment, or disclosure and likely trigger further engagement. The Board recommends FOR and has disclosed engagement activities and prior vote results to justify continuity in policy and program design.

  4. 4

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.

  5. 5

    Re-appointment of Deloitte LLP as the Company’s U.K. Statutory Auditor Under the Companies Act

    ManagementBoard: FOR

    Re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act to hold office until the next AGM at which accounts are laid.

  6. 6

    Authorization of the Audit Committee to Determine the Company’s U.K. Statutory Auditor’s Remuneration

    ManagementBoard: FOR

    Authorize the Audit Committee of the Board to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.

    More detail

    This ordinary resolution asks shareholders to delegate authority to the Audit Committee to fix the U.K. statutory auditor’s remuneration. Under the Companies Act, auditor fees may be set at a general meeting or by a mechanism decided by shareholders; the Company proposes the Audit Committee perform this task for administrative efficiency and to leverage the committee’s oversight of audit matters. The Board’s recommendation reflects standard U.K. practice—giving the committee the ability to negotiate and approve fees in the context of audit scope, independence and non‑audit work limits. For an analyst evaluating governance, delegation concentrates fee negotiation with directors possessing audit expertise but also requires robust committee procedures to avoid conflicts and preserve auditor independence. The resolution is routine in U.K.-incorporated issuers and does not alter audit scope or the Audit Committee’s prerogatives; it simply authorizes fee determination. Passage supports timely fee arrangements and ongoing auditor engagement; failure to pass would require shareholder-level fee approvals and could complicate standard audit administration. The Board recommends FOR, citing the Audit Committee’s role in overseeing auditor selection and services and its review of non‑audit fees to preserve independence.

  7. 7

    Authorization of the Board to Allot Equity Securities in the Company

    ManagementBoard: FOR

    Authorize the Board to allot equity securities up to an aggregate nominal amount equal to approximately 20% of the Company’s issued share capital (aggregate nominal amount $509,171) until the earlier of the 2027 AGM or September 4, 2027.

    More detail

    This ordinary resolution asks shareholders to grant the Board authority under section 551 of the Companies Act to allot shares or grant rights to subscribe for or convert securities into shares up to an aggregate nominal amount equal to approximately 20% of issued share capital (stated as $509,171). Management frames the request as a legal formality for U.K. public companies—without this authority directors would lose the ability to issue shares until shareholders renew the power. The flexibility supports routine corporate financing, satisfaction of equity incentive plans, acquisitions and other corporate transactions, subject to existing NYSE shareholder approval requirements where applicable. The proposal includes customary safeguards (ability to deal with treasury shares, fractional entitlements, record dates and cross‑jurisdictional legal issues) and a limited duration (until the 2027 AGM or September 4, 2027). For an analyst, important considerations include the size of the authority (20% is at the higher end of commonly requested annual authorities but within market practice for companies seeking flexibility), potential dilution to existing shareholders, and the interaction with the companion disapplication of pre‑emption rights in Proposal 8. Board support and the annual renewal practice reduce transaction risk, but investors should monitor subsequent issuance activity and purposes (e.g., capital raising vs. employee plan dilution). The Board recommends FOR to preserve operational and financing flexibility under U.K. law.

  8. 8

    Subject to the Passing of Proposal 7, Authorization of the Board to Allot Equity Securities Without Pre-emptive Rights

    ManagementBoard: FOR

    Special resolution (requiring 75% approval) to disapply statutory pre-emption rights and permit the Board to allot equity securities for cash (or sell treasury shares) up to an aggregate nominal amount of $509,171 (approximately 20% of issued share capital), until the earlier of the 2027 AGM or September 4, 2027.

    More detail

    This special resolution seeks shareholder approval to disapply statutory pre‑emption rights so the Board can issue equity securities for cash (or sell treasury shares) up to ~20% of issued share capital without offering them pro rata to existing shareholders. Management emphasizes this is customary under U.K. practice and necessary to preserve the Company’s ability to raise capital quickly, satisfy share‑based compensation plans, or pursue strategic transactions. The proposal is subject to the passing of Proposal 7 (the allotment authority) and requires a 75% majority because it disapplies shareholder pre‑emption protections. Analysts should assess the proposed size (20%) against recent issuance history and potential dilutive impact; when paired with appropriate disclosure and limited renewal periods, it is a market‑standard flexibility mechanism. The Board notes that NYSE approval rules remain applicable where relevant and that this resolution does not change those external requirements. Passage typically indicates shareholders’ willingness to permit the Board tactical flexibility; failure to pass could constrain capital market responsiveness and complicate equity plan operation. The Board recommends FOR.

Director elections

Nominees on the ballot8

Independent
Tenure on this board
1.3 yrs
Also a director at
Howmet Aerospace Inc (HWM)
Not independent
Tenure on this board
8.9 yrs
Independent
Tenure on this board
7.4 yrs
Also a director at
Diamondback Energy Inc (FANG)Lci Industries (LCII)
Independent
Tenure on this board
6.0 yrs
Also a director at
Toppoint Holdings Inc (TOPP)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.8.2%20,772,449$470M
2VANGUARD PORTFOLIO MANAGEMENT LLC5.2%13,091,414$296M
3FMR LLC5.0%12,683,880$287M
4Allspring Global Investments Holdings, LLC4.9%12,411,331$286M
5VANGUARD CAPITAL MANAGEMENT LLC4.5%11,419,085$258M
6DIMENSIONAL FUND ADVISORS LP4.3%10,892,981$246M
7Neuberger Berman Group LLC3.2%8,078,890$183M
8STATE STREET CORP3.2%8,068,538$182M
9FRANKLIN RESOURCES INC3.0%7,513,345$170M
10JPMORGAN CHASE CO2.9%7,256,128$153M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Gates Industrial Corp PLC 2026 annual meeting?
Gates Industrial Corp PLC (GTES) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
What is the record date for the Gates Industrial Corp PLC 2026 meeting?
The record date for the Gates Industrial Corp PLC 2026 meeting is Tuesday, April 7, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Gates Industrial Corp PLC's 2026 meeting?
The board is presenting 8 director nominees at the Gates Industrial Corp PLC 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Gates Industrial Corp PLC 2026 meeting?
Shareholders will vote on 8 proposals at the Gates Industrial Corp PLC 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer